HLA-B44 Polymorphisms at Position 116 of the Heavy Chain Influence TAP Complex Binding via an Effect on Peptide Occupancy

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, United States
The Journal of Immunology (Impact Factor: 4.92). 10/2006; 177(5):3150-61. DOI: 10.4049/jimmunol.177.5.3150
Source: PubMed


A single residue polymorphism distinguishes HLA-B*4402(D116) from HLA-B*4405(Y116), which was suggested to allow HLA-B*4405 to acquire peptides without binding to tapasin-TAP complexes. We show that HLA-B*4405 is not inherently unable to associate with tapasin-TAP complexes. Under conditions of peptide deficiency, both allotypes bound efficiently to TAP and tapasin, and furthermore, random nonamer peptides conferred higher thermostability to HLA-B*4405 than to HLA-B*4402. Correspondingly, under conditions of peptide sufficiency, more rapid peptide-loading, dissociation from TAP complexes, and endoplasmic reticulum exit were observed for HLA-B*4405, whereas HLA-B*4402 showed greater endoplasmic reticulum retention and enhanced tapasin-TAP binding. Together, these studies suggest that position 116 HLA polymorphisms influence peptide occupancy, which in turn determines binding to tapasin and TAP. Relative to HLA-B*4405, inefficient peptide loading of HLA-B*4402 is likely to underlie its stronger tapasin dependence for cell surface expression and thermostability, and its enhanced susceptibility to pathogen interference strategies.

Download full-text


Available from: Kathleen Loretta Collins
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: HIV-1 establishes a chronic infection. To facilitate viral infection and spread, HIV-1 Nef disrupts the surface expression of the viral receptor (CD4) and antigen presenting molecules (MHC-I). Nef binds the cytoplasmic tails of both molecules and disrupts their trafficking using separate mechanisms that are incompletely understood. We demonstrate here that these distinct mechanisms are dictated by differences in the cytoplasmic tails of CD4 and MHC-I. Despite these differences, we demonstrate that MHC-I and CD4 are ultimately targeted to the same degradative compartments via interaction of Nef with the cellular protein -COP. Moreover, we demonstrate that the N-terminal -helical and dimerization domains of Nef are required for the Nef/-COP interaction. These findings have revealed the convergence of separate degradative pathways for CD4 and MHC-I, providing insight into the mechanisms used by HIV to evade the immune response. The removal of MHC-I from the cell surface protects HIV-infected cells from cytotoxic T lymphocytes. However, complete downmodulation of MHC-I by HIV Nef would render the infected cell susceptible to NK cell-mediated destruction. This scenario may be avoided by Nef’s inability to downmodulate certain MHC-I alleles, HLA-C and HLA-E, which inhibit NK cells. In the present work, we sought to better understand the biology of HLA-C in order to discern its role in HIV infection. Compared to other classical MHC-I allotypes, HLA-C has low cell surface expression and altered intracellular trafficking. Our studies have revealed that aspects of HLA-C trafficking are controlled by both the extracellular and cytosolic domains, in both CD4+ T cells and macrophages. Interestingly, we also found that HLA-C expression is upregulated upon macrophage differentiation, revealing the possibility of previously uncharacterized roles for HLA-C in the immune system. These studies bring us closer to understanding the role of HLA-C in the immune system and in HIV infection. The studies described in this thesis further our understanding of the interplay between HIV and the host immune system and provide insight into the biology of HLA-C in T cells and macrophages. Collectively, these data contribute significantly to our knowledge in areas crucial for the development of better antiretroviral therapies and vaccine strategies. Ph.D. Immunology University of Michigan, Horace H. Rackham School of Graduate Studies http://deepblue.lib.umich.edu/bitstream/2027.42/58478/1/mschaefe_1.pdf
    Preview · Article ·
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Tapasin (Tpn) has been implicated in multiple steps of the MHC class I assembly pathway, but the mechanisms of function remain incompletely understood. Using purified proteins, we could demonstrate direct binding of Tpn to peptide-deficient forms of MHC class I molecules at physiological temperatures. Tpn also bound to M10.5, a pheromone receptor-associated MHC molecule that has an open and empty groove and that shares significant sequence identity with class I sequences. Two types of MHC class I-Tpn complexes were detectable in vitro depending on the input proteins; those depleted in beta(2)m, and those containing beta(2)m. Both were competent for subsequent assembly with peptides, but the latter complexes assembled more rapidly. Thus, the assembly rate of Tpn-associated class I was determined by the conditions under which Tpn-MHC class I complexes were induced. Peptide loading of class I inhibited Tpn-class I-binding interactions, and peptide-depletion enhanced binding. In combination with beta(2)m, certain peptides induced efficient dissociation of preformed Tpn-class I complexes. Together, these studies demonstrate direct Tpn-MHC class I interactions and preferential binding of empty MHC class I by Tpn, and that the Tpn-class I interaction is regulated by both beta(2)m and peptide. In cells, Tpn is likely to be a direct mediator of peptide-regulated binding and release of MHC class I from the TAP complex.
    Preview · Article · Dec 2006 · Proceedings of the National Academy of Sciences
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Prior to binding to a high affinity peptide and transporting it to the cell surface, major histocompatibility complex class I molecules are retained inside the cell by retention in the endoplasmic reticulum (ER), recycling through the ER-Golgi intermediate compartment and possibly the cis-Golgi, or both. Using fluorescence microscopy and a novel in vitro COPII (ER-to-ER-Golgi intermediate compartment) vesicle formation assay, we find that in both lymphocytes and fibroblasts that lack the functional transporter associated with antigen presentation, class I molecules exit the ER and reach the cis-Golgi. Intriguingly, in wild-type T1 lymphoma cells, peptide-occupied and peptide-receptive class I molecules are simultaneously exported from ER membranes with similar efficiencies. Our results suggest that binding of high affinity peptide and exit from the ER are not coupled, that the major histocompatibility complex class I quality control compartment extends into the Golgi apparatus under standard conditions, and that peptide loading onto class I molecules may occur in post-ER compartments.
    Full-text · Article · Nov 2007 · Journal of Biological Chemistry
Show more